Stimulus-selective crosstalk via the NF-κB signaling system reinforces innate immune response to alleviate gut infection

eLife

Volumn 2015, Issue 4, 2015, Pages 1-56

  Banoth, Balaji ^a   Chatterjee, Budhaditya ^a   Vijayaragavan, Bharath ^a   Prasad, M V R ^a   Roy, Payel ^a   Basak, Soumen ^a  

^a NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

Author keywords

Citrobacter rodentium; Inflammation; Innate immunity; Lymphotoxin; Positive feedback; RelA:p52 NF B

Indexed keywords

ADENINE NUCLEOTIDE TRANSLOCASE; BENZODIAZEPINE RECEPTOR; BENZODIAZEPINE RECEPTOR ASSOCIATED PROTEIN I; CARRIER PROTEIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; GLYCOGEN SYNTHASE KINASE 3BETA; HEXOKINASE 1; INTERLEUKIN 1; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; REACTIVE OXYGEN METABOLITE; TSPO PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VOLTAGE DEPENDENT ANION CHANNEL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYMPHOTOXIN BETA RECEPTOR; NFKB2 PROTEIN, MOUSE; RELA PROTEIN, MOUSE; TRANSCRIPTION FACTOR RELA;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; AMYOTROPHIC LATERAL SCLEROSIS; ANXIETY DISORDER; APOPTOSIS; ARTICLE; BRAIN ISCHEMIA; CELL PROLIFERATION; CEREBROVASCULAR ACCIDENT; HUMAN; HUNTINGTON CHOREA; MENTAL DISEASE; MULTIPLE SCLEROSIS; PARKINSON DISEASE; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; STEROIDOGENESIS; UPREGULATION; ANIMAL; C57BL MOUSE; CITROBACTER RODENTIUM; DEFICIENCY; ENTEROBACTERIACEAE INFECTION; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; INFLAMMATION; INNATE IMMUNITY; INTESTINE MUCOSA; KNOCKOUT MOUSE; MICROBIOLOGY; MOUSE; PATHOGENICITY; SIGNAL TRANSDUCTION;

CITROBACTER RODENTIUM; MUS;

ANIMALS; CITROBACTER RODENTIUM; ENTEROBACTERIACEAE INFECTIONS; GENE EXPRESSION REGULATION; IMMUNITY, INNATE; INFLAMMATION; INTESTINAL MUCOSA; LYMPHOTOXIN BETA RECEPTOR; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-KAPPA B; NF-KAPPA B P52 SUBUNIT; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELA;

EID: 84929165316     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.05648     Document Type: Article

References (44)

1. Stout, R. D. and Suttles, J. Functional plasticity of macrophages: reversible adaptation to changing microenvironments. J Leukoc Biol 76, 509-513, doi:10.1189/jlb.0504272 (2004).
2. 2 Iwasaki, A. and Kelsall, B. L. Freshly isolated Peyer's patch, but not spleen, dendritic cells produce interleukin 10 and induce the differentiation of T helper type 2 cells. J Exp Med 190, 229-239 (1999).
3. Pluvinet, R. et al. CD40: an upstream master switch for endothelial cell activation uncovered by RNAi-coupled transcriptional profiling. Blood 112, 3624-3637, doi:10.1182/blood-2008-03-143305 (2008).
4. Spahn, T. W. et al. The lymphotoxin-beta receptor is critical for control of murine Citrobacter rodentium-induced colitis. Gastroenterology 127, 1463-1473, doi:S0016508504014301 [pii] (2004).
5. Wang, Y. et al. Lymphotoxin beta receptor signaling in intestinal epithelial cells orchestrates innate immune responses against mucosal bacterial infection. Immunity 32, 403-413, doi:10.1016/j.immuni.2010.02.011 (2010).
6. Sun, S. C. The noncanonical NF-kappaB pathway. Immunol Rev 246, 125-140, doi:10.1111/j.1600-065X.2011.01088.x (2012).
7. Bonizzi, G. et al. Activation of IKKalpha target genes depends on recognition of specific kappaB binding sites by RelB:p52 dimers. The EMBO journal 23, 4202-4210, doi:10.1038/sj.emboj.7600391 (2004).
8. Savinova, O. V., Hoffmann, A. and Ghosh, G. The Nfkb1 and Nfkb2 proteins p105 and p100 function as the core of high-molecular-weight heterogeneous complexes. Mol Cell 34, 591-602, doi:S1097-2765(09)00316-5 [pii] 10.1016/j.molcel.2009.04.033 (2009).
9. Basak, S. et al. A fourth IkappaB protein within the NF-kappaB signaling module. Cell 128, 369-381, doi:10.1016/j.cell.2006.12.033 (2007).
10. 10 Legarda-Addison, D. and Ting, A. T. Negative regulation of TCR signaling by NF-kappaB2/p100. J Immunol 178, 7767-7778 (2007).
11. Shih, V. F. et al. Kinetic control of negative feedback regulators of NF-kappaB/RelA determines their pathogen- and cytokine-receptor signaling specificity. Proceedings of the National Academy of Sciences of the United States of America 106, 9619-9624, doi:0812367106 [pii]10.1073/pnas.0812367106 (2009).
12. 12 de Wit, H. et al. Regulation of p100 (NFKB2) expression in human monocytes in response to inflammatory mediators and lymphokines. Leukemia 12, 363-370 (1998).
13. Hoffmann, A., Leung, T. H. and Baltimore, D. Genetic analysis of NF-kappaB/Rel transcription factors defines functional specificities. The EMBO journal 22, 5530-5539, doi:10.1093/emboj/cdg534 (2003).
14. Basak, S., Behar, M. and Hoffmann, A. Lessons from mathematically modeling the NF-kappaB pathway. Immunol Rev 246, 221-238, doi:10.1111/j.1600-065X.2011.01092.x (2012).
15. Hoffmann, A., Levchenko, A., Scott, M. L. and Baltimore, D. The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation. Science 298, 1241-1245, doi:10.1126/science.1071914 (2002).
16. Werner, S. L. et al. Encoding NF-kappaB temporal control in response to TNF: distinct roles for the negative regulators IkappaBalpha and A20. Genes Dev 22, 2093-2101, doi:10.1101/gad.1680708 (2008).
17. Covert, M. W., Leung, T. H., Gaston, J. E. and Baltimore, D. Achieving stability of lipopolysaccharide-induced NF-kappaB activation. Science 309, 1854-1857, doi:10.1126/science.1112304 (2005).
18. Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences of the United States of America 102, 15545-15550, doi:10.1073/pnas.0506580102 (2005).
19. Tao, Z. et al. p100/IkappaBdelta sequesters and inhibits NF-kappaB through kappaBsome formation. Proceedings of the National Academy of Sciences of the United States of America, doi:10.1073/pnas.1408552111 (2014).
20. Fusco, A. J. et al. Stabilization of RelB requires multidomain interactions with p100/p52. J Biol Chem 283, 12324-12332, doi:10.1074/jbc.M707898200 (2008).
21. 21 Weih, F. et al. Both multiorgan inflammation and myeloid hyperplasia in RelB-deficient mice are T cell dependent. J Immunol 157, 3974-3979 (1996).
22. Shih, V. F. et al. Control of RelB during dendritic cell activation integrates canonical and noncanonical NF-kappaB pathways. Nature immunology 13, 1162-1170, doi:10.1038/ni.2446 (2012).
23. Natoli, G., Saccani, S., Bosisio, D. and Marazzi, I. Interactions of NF-kappaB with chromatin: the art of being at the right place at the right time. Nature immunology 6, 439-445, doi:10.1038/ni1196 (2005).
24. Zhao, B. et al. The NF-kappaB genomic landscape in lymphoblastoid B cells. Cell reports 8, 1595-1606, doi:10.1016/j.celrep.2014.07.037 (2014).
25. Siggers, T. et al. Principles of dimer-specific gene regulation revealed by a comprehensive characterization of NF-kappaB family DNA binding. Nature immunology 13, 95-102, doi:10.1038/ni.2151 (2012).
26. Upadhyay, V. and Fu, Y. X. Lymphotoxin signalling in immune homeostasis and the control of microorganisms. Nat Rev Immunol 13, 270-279, doi:10.1038/nri3406 (2013).
27. 27 Alcamo, E. et al. Targeted mutation of TNF receptor I rescues the RelA-deficient mouse and reveals a critical role for NF-kappa B in leukocyte recruitment. J Immunol 167, 1592-1600 (2001).
28. Shui, J. W. et al. HVEM signalling at mucosal barriers provides host defence against pathogenic bacteria. Nature 488, 222-225, doi:10.1038/nature11242 (2012).
29. 29 Caamano, J. H. et al. Nuclear factor (NF)-kappa B2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses. J Exp Med 187, 185-196 (1998).
30. Hu, H. et al. OTUD7B controls non-canonical NF-kappaB activation through deubiquitination of TRAF3. Nature 494, 371-374, doi:10.1038/nature11831 (2013).
31. Lo, J. C. et al. Coordination between NF-kappaB family members p50 and p52 is essential for mediating LTbetaR signals in the development and organization of secondary lymphoid tissues. Blood 107, 1048-1055, doi:10.1182/blood-2005-06-2452 (2006).
32. Yilmaz, Z. B., Weih, D. S., Sivakumar, V. and Weih, F. RelB is required for Peyer's patch development: differential regulation of p52-RelB by lymphotoxin and TNF. The EMBO journal 22, 121-130, doi:10.1093/emboj/cdg004 (2003).
33. Maaser, C. et al. Clearance of Citrobacter rodentium requires B cells but not secretory immunoglobulin A (IgA) or IgM antibodies. Infect Immun 72, 3315-3324, doi:10.1128/IAI.72.6.3315-3324.2004 (2004).
34. 34 Simmons, C. P. et al. Central role for B lymphocytes and CD4+ T cells in immunity to infection by the attaching and effacing pathogen Citrobacter rodentium. Infect Immun 71, 5077-5086 (2003).
35. Shinohara, H. et al. Positive feedback within a kinase signaling complex functions as a switch mechanism for NF-kappaB activation. Science 344, 760-764, doi:10.1126/science.1250020 (2014).
36. Sung, M. H. et al. Switching of the relative dominance between feedback mechanisms in lipopolysaccharide-induced NF-kappaB signaling. Science signaling 7, ra6, doi:10.1126/scisignal.2004764 (2014).
37. Mordmuller, B., Krappmann, D., Esen, M., Wegener, E. and Scheidereit, C. Lymphotoxin and lipopolysaccharide induce NF-kappaB-p52 generation by a co-translational mechanism. EMBO Rep 4, 82-87, doi:10.1038/sj.embor.embor710 (2003).
38. Lee, T. K. et al. A noisy paracrine signal determines the cellular NF-kappaB response to lipopolysaccharide. Science signaling 2, ra65, doi:10.1126/scisignal.2000599 (2009).
39. Khan, M. A. et al. Toll-like receptor 4 contributes to colitis development but not to host defense during Citrobacter rodentium infection in mice. Infect Immun 74, 2522-2536, doi:10.1128/IAI.74.5.2522-2536.2006 (2006).
40. 40 Ishikawa, H., Carrasco, D., Claudio, E., Ryseck, R. P. and Bravo, R. Gastric hyperplasia and increased proliferative responses of lymphocytes in mice lacking the COOH-terminal ankyrin domain of NF-kappaB2. J Exp Med 186, 999-1014 (1997).
41. Allen, I. C. et al. NLRP12 suppresses colon inflammation and tumorigenesis through the negative regulation of noncanonical NF-kappaB signaling. Immunity 36, 742-754, doi:10.1016/j.immuni.2012.03.012 (2012).
42. Tumanov, A. V. et al. Lymphotoxin controls the IL-22 protection pathway in gut innate lymphoid cells during mucosal pathogen challenge. Cell Host Microbe 10, 44-53, doi:10.1016/j.chom.2011.06.002 (2011).
43. 43 Zhu, X. et al. Dual ligand stimulation of RAW 264.7 cells uncovers feedback mechanisms that regulate TLR-mediated gene expression. J Immunol 177, 4299-4310 (2006).
44. Greten, F. R. et al. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118, 285-296, doi:10.1016/j.cell.2004.07.013 (2004).